PGFC
SRNE

Peapack-Gladstone Financial Corp’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,200
Closed -$16K – 710
2022
Q3 		$16K Sell
10,200
-91
-0.9% -$206 ﹤0.01% 682
2022
Q2 		$21K Hold
10,291
– – ﹤0.01% 652
2022
Q1 		$24K Buy
10,291
+91
+0.9% +$284 ﹤0.01% 690
2021
Q4 		$47K Hold
10,200
– – ﹤0.01% 676
2021
Q3 		$78K Hold
10,200
– – ﹤0.01% 661
2021
Q2 		$99K Sell
10,200
-700
-6% -$5.58K ﹤0.01% 620
2021
Q1 		$90K Buy
10,900
+700
+7% +$7.39K ﹤0.01% 587
2020
Q4 		$70K Buy
+10,200
New +$81.9K ﹤0.01% 428

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM